Investigational Medication For Obesity In Those With Fatty Liver Disease
AMR Knoxville is conducting a study testing different doses of an investigational medication for people who are overweight and have non-alcoholic fatty liver disease.
Qualified participants must:
- be ages 18 to 75
- be considered medically overweight or obese
- have non-alcoholic fatty liver disease (NASH)
- be willing to complete this 18-week study with 17 visits in our research center
- meet other study criteria
Receive all study-related care and the investigational medication or placebo at no cost. Compensation is available up to $6,950.00 for time and travel.
Let AMR Knoxville see if you qualify! Call 865-305-DRUG (3784) today!